The shares of Johnson & Johnson (NYSE:JNJ) traded with a loss of -0.17 points or -0.14% in the most recent session. The shares last traded at $116.38. As per the trading info, the shares saw $87.95 million in upticks and lost $72.1 million in downticks, resulting in a net money flow of $15.85 million. The up/down ratio for the day was measured at 1.22. For the week, the shares had posted 0.78%.From the block trade data available, the total upticks were valued at $12.86 million and the total downticks were valued at $3.49 million, thereby putting the up/down ratio at 3.69. The net money flow for the block transaction was $9.38 million.
The stock has recorded a 20-day Moving Average of 1.06% and the 50-Day Moving Average is 2.75%. The company shares have rallied 16.8% in the past 52 Weeks. On June 15, 2016 The shares registered one year high of $117.74 and one year low was seen on August 24, 2015 at $81.79. The 50-day moving average is $114.3 and the 200 day moving average is recorded at $107.38. S&P 500 has rallied 1.93% during the last 52-weeks.
Johnson & Johnson (NYSE:JNJ): The stock opened at $116.99 on Tuesday but the bulls could not build on the opening and the stock topped out at $117.15 for the day. The stock traded down to $116.18 during the day, due to lack of any buying support eventually closed down at $116.18 with a loss of -0.31% for the day. The stock had closed at $116.54 on the previous day. The total traded volume was 5,493,490 shares.
Currently the company Insiders own 0.11% of Johnson & Johnson shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -18.24% . Institutional Investors own 67.95% of Johnson & Johnson shares. During last six month period, the net percent change held by insiders has seen a change of -18.24%. On the companys insider trading activities, Pruden Gary J, officer (Exec VP, WW Chair, Med Devices) of Johnson & Johnson, unloaded 9,735 shares at an average price of $116.03 on June 7, 2016. The total amount of the transaction was worth $1,129,552, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.